Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Rulan Yin, Jingya Lu, Zuocheng Xu, Qianqian Yan, Mingjun Wang & Rong Xu. (2023) Urate-lowering therapy adherence and the association with medication beliefs, self-efficacy, depression, anxiety, and COVID-19 pandemic-related concern in Chinese gout patients: a cross-sectional study. Psychology, Health & Medicine 28:7, pages 1698-1708.
Read now
Read now
Sunggun Lee, Min Wook So & Eunyoung Ahn. (2019) Long-term adherence and persistence with febuxostat among male patients with gout in a routine clinical setting. Modern Rheumatology 29:4, pages 662-668.
Read now
Read now
Articles from other publishers (11)
Min Wook So, A‐Ran Kim & Seung‐Geun Lee. (2023) Analysis of appropriate duration of colchicine prophylaxis to maximize the persistence of xanthine oxidase inhibitors as the first‐line urate‐lowering therapy in patients with gout using the Korean Health Insurance Review and Assessment Service database. International Journal of Rheumatic Diseases 26:9, pages 1770-1778.
Crossref
Crossref
Xiaoli Li, Qin Shao, Jingfang Shen, Shaohui Ren, Lianju Li, Hua Lu & Shubo Chen. (2023) Association between the initial dose urate-lowering drugs and gout flares in adult males with gout. Rheumatology.
Crossref
Crossref
Joong Kyong Ahn. (2023) Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean. Journal of Rheumatic Diseases 30:2, pages 88-98.
Crossref
Crossref
Cheng Shi, Ziting Zhou, Xiaowei Chi, Siyu Xiu, Chuxiao Yi, Ziqiong Jiang, Ruyi Chen, Liangren Zhang & Zhenming Liu. (2023) Recent advances in gout drugs. European Journal of Medicinal Chemistry 245, pages 114890.
Crossref
Crossref
Esha Dasgupta, Zhan P. Chong, Ming N. Ting, Amirul A. Mohd Tajuddin, Ke X. Voon, Tharsyini Sasitharan, Keen S. Tai & Swan S. Yeap. (2022) Relationship of medication adherence, serum uric acid level and diet to recurrent attacks of gout. The Egyptian Rheumatologist 44:1, pages 69-73.
Crossref
Crossref
Gary H. Ho, Michael H. Pillinger & Michael Toprover. (2021) Adherence to gout guidelines: where do we stand?. Current Opinion in Rheumatology 33:2, pages 128-134.
Crossref
Crossref
Aran Kim, Yunkyung Kim, Geun-Tae Kim, Eunyoung Ahn, Min Wook So & Seung-Geun Lee. (2020) Comparison of persistence rates between allopurinol and febuxostat as first-line urate-lowering therapy in patients with gout: an 8-year retrospective cohort study. Clinical Rheumatology 39:12, pages 3769-3776.
Crossref
Crossref
Eeunyoung AhnSunggun LeeHan-Na LeeSeung-Geun LeeMin Wook So. (2019) Comparison of Efficacy and Safety of Febuxostat in Gout Patients with Chronic Kidney Disease Stage 3 and Stage 4/5. Journal of Rheumatic Diseases 26:2, pages 118.
Crossref
Crossref
Lieke E J M Scheepers, Andrea M Burden, Ilja C W Arts, Bart Spaetgens, Patrick Souverein, Frank de Vries & Annelies Boonen. (2018) Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD). Rheumatology 57:9, pages 1641-1650.
Crossref
Crossref
Hisashi Yamanaka, Shigenori Tamaki, Yumiko Ide, Hyeteko Kim, Kouichi Inoue, Masayuki Sugimoto, Yuji Hidaka, Atsuo Taniguchi, Shin Fujimori & Tetsuya Yamamoto. (2018) Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study. Annals of the Rheumatic Diseases 77:2, pages 270-276.
Crossref
Crossref
In-Soo Yoon, Dae-Hun Park, Min-Suk Bae, Deuk-Sil Oh, Nan-Hui Kwon, Jung-Eun Kim, Chul-Yung Choi & Seung-Sik Cho. (2017)
In Vitro and In Vivo Studies on
Quercus acuta
Thunb. (Fagaceae) Extract: Active Constituents, Serum Uric Acid Suppression, and Xanthine Oxidase Inhibitory Activity
. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-9.
Crossref
Crossref